We know from well-publicised outcome data that early detection of prostate cancer can save lives. PCSO is now formally encouraging interested men, especially those in the highest risk groups for prostate cancer or who may have difficulty obtaining a medical practitioner’s requestion, to take advantage of a pilot program offered through LifeLabs® to screen for prostate cancer with a simple blood test for prostate specific antigen (PSA). PCSO will re-imburse the $71 LifeLabs® charge to any man who elects to undergo this procedure. Please check out the poster with full program details at the link below.
